Mumbai, Oct 7:

The Association of Biotechnology Led Enterprises (ABLE), the apex body of the biotechnology sector in India, and the US-based Washington Biotechnology and Biomedical Association (WBBA) have signed a memorandum of understanding (MoU) to enable broad ranging co-operation in the field of biotechnology. The duo will support breakthrough discoveries in healthcare, agriculture and clean energy in the country.

Both ABLE and WBBA are to provide each others members an opportunity to co-operate and invest in the State of Washington and in India, in the field of biotechnology. These activities could be current ones that both associations are engaged in, or future ones that both may decide to do individually or jointly.

Activities could concern technical knowledge, market research, inputs for policy making, internships, exhibitions, workshops, seminars, capacity building, collaborations, investment and business partnering.

P. M. Murali, President, ABLE said, The collaboration aims to achieve breakthrough discoveries to provide affordable solutions for critical diseases, important challenges in agriculture and energy on mutually agreed topics.'

Chris Rivera, President, WBBA said, We see India as the growth engine of tomorrow and one of the fastest growing economies in the world. The collaboration with ABLE is significant to facilitate best of research in biotechnology from both the countries.

Link:
Biotech bodies in investment tie-up